Acknowledgements
We are grateful to the patient and his family for their participation in this study. We thank Beijing McGinow Technology Co. for their technical support in gene sequencing and data analysis. We would also like to acknowledge the clinical staff of the Endocrinology Department of Beijing Children’s Hospital and the Neonatal Department of Capital Institute of Pediatrics for their assistance in the present study.
[1] Shepherd, M.et al.Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K.Pediatric Diabetes Population With Monogenic Diabetes.Diabetes Care, 39: 1879-1888, doi:10.2337/dc16-0645 (2016).
[2] Bansal, V.et al.Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals. BMC medicine 15, 213, doi:10.1186/s12916-017-0977-3 (2017).
[3] Anik A, et al. Maturity-onset diabetes of the young(MODY): an update[J].J Pediatr Endocrinol Metab, 2015, 28(34): 25l-263. DOI:10.1515/jpem-2014-0384.
[4] Froguel P,Vaxillaire M. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes.[J]. 2008, 29(3).
[5] Hattersley AT, SAW G, Polak M, et al. ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents[J]. Pediatr Diabetes, 2018,19 Suppl 27: 47‐63. DOI: 10.1111/pedi.12772
[6] FlannickJ,Beer NL,Bick AG,et al.Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes[J].Nat Genet, 2013, 45(11):1380-1385.
[7] Bowman P, Flanagan S, Edghill E, et al. Heterozygous ABCC8 mutations are a cause of MODY[J].Diabetologia, 2012,55(1): 123-127.
[8] Bonnefond A, Philippe J, Durand E, et al. Whole-exome sequencing and high through put genotyping identified KCNJ11 as the thirteenth MODY gene[J].PLoS One,2012,7(6):e37423.
[9] Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.N Engl J Med, 345(13):971–980
[10] Plengvidhya N, Kooptiwut S, Songtawee N, et al. PAX4 mutations in Thais with maturity onset diabetes of the young[J]. J ClinEndocrinol Metab, 2007, 92(7): 2821-2826.
[11] Brun T, Franklin I, St-Onge L, Biason-Lauber A, Schoenle EJ, Wollheim CB et al (2004) The diabetes-linked transcription factor PAX4 promotes beta-cell proliferation and survival in rat and human islets. J Cell Biol 167(6):1123–1135.
[12] Mansouri A, Goudreau G, Gruss P. Pax genes and their role in organogenesis. Cancer Res, 1999;59: 1707–9.
[13] Antojenifer Panneerselvam, Arun Kannan, et al. PAX proteins and their role in pancreas. Diabetes research and clinical practice 155(2019)107792;
[14] Sosa-Pineda B, ChowdhuryK, Torres M, et al. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas[J]. Nature,1997,386(6623):399-402. DOI: 10.1038/386399a0
[15] Habener JF, Kemp DM, Thomas MK. 2005 Minireview transcriptional regulation in pancreatic development. Endocrinology 146:1025–1034.
[16] Wang J, Elghazi L, Parker SE, Kizilocak H, Asano M, Sussel L, Sosa-Pineda B 2004 The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic β-cell differentiation. Dev Biol, 266:178 –189.
[17] Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P 1997 The Pax4 gene is essential for differentiation of insulin-producing β cells in the mam-malian pancreas. Nature 386:399-402
[18] T Zhang, HW Wang, et al. Pax4 synergistically acts with Pdx1, Ngn3 and MafA to induce HuMSCs to differentiate into functional pancreatic β-cells. Experimental and Therapeutic Medicine. 2019, 18: 2592-2598.
[19] Marc Gregory Yu, Hillary A. Keenan, Hetal S. Shah, et al. Residual β cell function and monogenic variants in long-duration type 1 diabetes patients. The Journal of Clinical Investigation. 2019;129(8):3252–3263.
[20] Jo W, Endo M, Ishizu K, et a1. A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young[J]. Tohoku J Exp Med, 2011, 223(2): 113-118.
[21] Serena Pezzilli, Ornella Ludovico(2018), Insights From Molecular Characterization of Adult Patients of Families With Multigenerational Diabetes. Diabetes 2018;67:137–145
[22] Natalia Zubkova, Fatima Burumkulova2, et al. High frequency of pathogenic and rare sequence variants in diabetes-related genes among Russian patients with diabetes in pregnancy, Acta Diabetologica 2019,https://doi.org/10.1007/s00592-018-01282-6
[23] Aaron Chapla, Mahesh Doddabelavangala Mruthyunjaya, et al. Maturity onset diabetes of the young in India – a distinctive mutation pattern identified through targeted next-generation sequencing, Clinical Endocrinology (2014), DOI: 10.1111/cen.12541
[24] Smith SB, Ee HC, Conners JR, German MS 1999 Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development. Mol Cell Biol, 19:8272–8280.